Loading

Commentary Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.33696/Signaling.4.088

Targeting SCUBE3 in Hepatocellular Carcinoma

  • 1Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China
+ Affiliations - Affiliations

Corresponding Author

Qiang Luo, qiangluo@hospital.cqmu.edu.cn

Received Date: January 17, 2023

Accepted Date: March 02, 2023

Abstract

HCC is one of the most common malignant tumors. The life and health of humans are gravely threatened by HCC because of its hidden onset, high recurrence rate, poor therapeutic effect, and high mortality. It is essential to explore the particular pathological mechanisms of HCC in order to increase the rate of early diagnosis and enhance patient therapy outcomes. Recent research has demonstrated that SCUBE3 can influence HCC cell proliferation by regulating the TGFβ/PI3K/AKT/GSK3β pathway. The molecular regulatory network of HCC proliferation is improved by this research, which also offers a solid theoretical and experimental foundation for SCUBE3 as a potential new therapeutic target for HCC.

Keywords

Hepatocellular carcinoma, SCUBE3, Cell proliferation, Targeted therapy, TβRII, PI3K/AKT, CCNE1

Author Information X